期刊文献+

雌激素对垂体催乳素细胞致瘤机制的探讨 被引量:2

The Mechanism of Estrogen in Estrogen Induced Prolactinoma Model in Rats
下载PDF
导出
摘要 背景与目的:探讨雌激素诱发大鼠垂体催乳素(PRL)瘤的发病机制。材料与方法:制备雌激素诱发大鼠PRL瘤模型:成年雄性Wistar大鼠16只,随机分为对照组(n=8)和PRL瘤组(n=8)。对照组皮下植入空白硅胶管,PRL瘤组皮下植入含有乙烯雌酚的硅胶管,用药8周后乙醚麻醉大鼠,心脏穿刺取血,分离血清,并开颅摘取垂体。采用放免法测定大鼠血清PRL水平;垂体称重并做组织病理学观察;用免疫组织化学方法检测垂体组织PRL蛋白的表达和分布;用RT_PCR方法检测c_fos和垂体肿瘤转化基因(PTTG)在PRL瘤组织中的表达,计算机凝胶成像系统分析其表达量。结果:雌激素作用8周后,根据大鼠垂体重量以及组织学和免疫组化的改变,证实已诱发出PRL瘤模型。在PRL瘤组中,c_fos和PTTG的表达量均明显高于对照组,二者差异具有统计学意义彩(P<0.001)。结论:雌激素刺激垂体PRL细胞表达癌基因c_fos以及PTTG,在雌激素诱发大鼠PRL细胞增生以至最终形成PRL瘤的过程中起一定的作用。 BACKGROUND & AIM: To study the mechanism of estrogen in an estrogen-induced prolactinoma model. MATERIALS AND MEthODS: ① Preparation of rat prolactinoma model: adult male Wistar rats were divided into 2 groups at random. Each rat in control group(n = 8)received a subcutaneous blank implant. Rats in prolactinoma group(n =8) received estrogen-containing implants. After 8 weeks, all the animals were sacrificed. ② Each pituitary gland was weighed and collected for histopathological and immunocytochemical examination. ③ Serum prolactin(PRL) levels were measured by RIA method. ④ Both c-fos mRNA level and pituitary tumor transforming gene (PTTG) mRNA level in pituitary tissue were measured by RT-PCR method. RESULTS: Prolactinoma model were prepared successfully as reflected by serum PRL level, pituitary weight and immunocytochemical examination. The expression levels of both c-fos mRNA and PTTG mRNA in prolactinoma group were obviously higher than those in control group(P 〈 0.001). CONCLUSION: Estrogen stimulated the expression of c-fos and PTTG oncogenes, which played important roles in estrogen-induced prolactinoma model.
作者 徐春 徐立红
出处 《癌变.畸变.突变》 CAS CSCD 2006年第6期435-438,共4页 Carcinogenesis,Teratogenesis & Mutagenesis
基金 国家自然科学基金资助项目(No.20137010) 首都医学发展科研基金(中医药类)资助项目(编号2001-Ⅲ-21)
关键词 雌激素 C-FOS 垂体肿瘤转化基因 催乳素瘤 estrogen c-fos pituitary tumor transforming gene(PTTG) prolactinomas
  • 相关文献

参考文献13

  • 1Chen WY,Hankinson SE,Schnitt SJ,et al.Association of hormone replacement to estrogen and progesterone receptor status in invasive breast carcinoma[J].Cancer,2004,101(7):1490-500.
  • 2Turan VK,Sanchez RI,Li JJ,et al.The effect of steroidal estrogens in ACI rat mammary carcinogenesis:17 beta-estradiol,2-hydroxyestradial,4-hydroxyestradial,16 alpha-hydroxyestradial,and 4-hydroxyestradial[J].J endocrinol,2004,183(1):91-99.
  • 3Zhang J,Sun Y,Liu Y,et al.Synergistic effects of androgen and estrogen on the uterus and mammary gland[J].Oncol Rep,2004,12(4):709-716.
  • 4徐春,李江源,黄兆坚.诺果宁、培高利特和降乳散对乙菧酚诱发的大鼠泌乳素瘤防治作用的初步研究[J].军医进修学院学报,2000,21(2):123-125. 被引量:8
  • 5Steinmetz R,Mitchner NA,Grant A,et al.The xenoestrogen bisphenol A induces growth,differentiation,and c-fos gene expression in the female reproductive tract[J].Endorinology,1998,139(6):2 741-2 747.
  • 6Heaney AP,Horwitz GA,Wang Z,et al.Early involement of estrogen-indused pituitary tumor transforming gene and fibroblast growth factor expression in prolactinoma pathogenesis[J].Nat Med,1999,5(11):1 317-21.
  • 7徐春,李江源,黄兆坚.雌激素受体基因在乙菧酚诱发的大鼠催乳素瘤中的表达[J].中华内分泌代谢杂志,2001,17(1):47-50. 被引量:11
  • 8Gutzman JH,Nikolai SE,Rogowski DE,et al.Prolactin and eatrogen enhance the activity of activating protein 1 in breast cacer:role of extracellularly regulated kinase 1/ 2-mediated signals to c-fos[J].Mol endocrinol,2005,19(7):1 765-1 778.
  • 9Boelaert K,McCabe CJ,Tannahill LA et al.Pituitary tumor transforming gene and fibroblast growth factor-2 expression:potential prognostic indicators in differentiated thyroid cancer[J].J Clin Endocrino Metab,2003,88(5):2 341-2 347.
  • 10Solbach C,Roller M,Fellbaum C,et al.PTTG mRNA expression in primary breast cancer:a prognostic marker for lymph node invasion and tumor recurrence[J].Breast,2004,13(1):80-81.

二级参考文献7

共引文献15

同被引文献13

  • 1Alesci S,Ramsey WJ,Bornstein SR,et al.Adonoviral vectors can impair adrenocorticai steroidogenesis:clinical implications for natural infections and gene therapy[J].Proc Natl Acad Sci USA,2002,99(11):7484-7489.
  • 2Lee EJ,Rachel W,Kotlar T,et al.Restoration of growth hormonereleasing hormone (GHRH) responsiveness in pituitary GH3 cells by adenovirus-directed expression of the human GHRH receptor[J].Endocrinol,2001,142 (1):414-420.
  • 3Ishida M,Takahashi W,Itoh S,et al.Estrogen actions on lactotroph proliferation are independent of a paracrine interaction with other pituitary cell types:a study using lactotrophenriched cells[J].Endocrinol,2007,148 (7):3131-3139.
  • 4Kawnshima K,Yamakawa K,Takahashi W,et al.The estrogonoccupied estrogen receptor functions as a negative regulator to inhibit cell proliferation induced by insulin/IGF-1:a cell contextspecific antimitogenic action of astradiol on rat lactotrophs in culture[J].Endocrinol,2002,143 (7):2750-2758.
  • 5Ishida M,Mitsui T,Yamakawa K,et al.Involvement of cAMP response element-binding protein in the regulation of cell proliferation and the prolactin promoter of lactotrophs in primary culture[J].Amer J Physiol,2007,293 (6):E1529-E1537.
  • 6Turin VK,Sanchez RI,Li JJ,et al.The effect of steroidal estrogens in ACI rat mammary carcinogenesis:17 beta-estradiol,2-hydroxyestradial,4-hydroxyestradinl,16 alpha-hydroxyestradial and 4-hydroxyestradial[J].J Endocrinol,2004,183(1):91-99.
  • 7Zhang J,Sun Y,Liu Y,et al.Synergistic effects of androgen and estrogen on the uterus and mammary gland[J].Oncol Rep,2004,12(4):709-716.
  • 8Dickson BB,Lippman ME.Growth factors in breast cancer[J].Endocrine Reviews,1995,16(5):559-589.
  • 9Durand MK.Bodker JS,Christensen A,et al.Plasminogen activator inhibitor-1 and tomour growth,invasion,and metastasis[J].Thromb Haemost,2004,91(3):438-449.
  • 10Abdollahi A.LOT1 (ZAC1/PLAGL1) and its family members:mechanisms and functions[J].J Cellul Physiol,2007,210(1):P16-25,.

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部